image

HWGB Biotech aims to provide a comprehensive range of big health products and solutions that adopts a preventive measure readily available to give a peace of mind of many around the world.

Backed by a panel of experienced consultants with relevant experience in the healthcare and technology industry in regards to matters involving healthcare and biotechnology.

+603-2143 8811 OR enquiry@hwgbbiotech.com

Media Details

  • Home
  • Media
  • Details
  2020-10-08 18:53:40

Ho Wah Genting Berhad Group aims to study the potential of nanoformulated dietary supplements

KUALA LUMPUR, 8 OCTOBER 2020 – Ho Wah Genting Berhad’s (“HWGB” or the “Company”) (Bursa Stock Code:9601) wholly-owned subsidiary, Astramern Sdn Bhd (“Astramern”) (FKA Astramune Sdn Bhd) had appointed Associate Professor Dr. Azmi Bin Rahmat, 65, (“AP Dr. Azmi”) as  ‘Chief of Material Engineering’ effective 7 October 2020. His expertise will contribute to the company’s research in raw material extraction for producing nanoparticles in healthcare supplements.

                                                                                                         Back
image

HWGB BIOTECH SDN BHD (Formerly known as HWG Consortium Sdn Bhd) [Company Number: 201201022032 (1006524-T)]

Our Business

Quick Links

Information

Privacy Policy   |  PDPA   |  Terms of Use

2020 HWGB Biotech. All rights Reserved.